Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026

CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, and provide a corporate update.

A live webcast of the call will be available under “Events and Presentations” in the Investors section of the Moderna website.

The archived webcast will be available on Moderna’s website approximately two hours after the conference call and will be available for one year following the call.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

Staff

Recent Posts

More than 130,000 Individuals Register to Save Lives Through MyChart Donor Registration Initiative

RICHMOND, Va., Jan. 28, 2026 /PRNewswire/ -- Donate Life America (DLA) announced today that more…

2 hours ago

Who Is the Best Plastic Surgeon In Washington State?

The best plastic surgeon in Washington is Dr. Sajan SEATTLE, WASHINGTON / ACCESS Newswire /…

2 hours ago

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities

LONDON, UK / ACCESS Newswire / January 28, 2026 / THE INFORMATION CONTAINED WITHIN THIS…

5 hours ago

Invitation to Cosmo’s Full Year 2025 Financial Results Webcast on 9 March 2026

Dublin, Ireland--(Newsfile Corp. - January 28, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

6 hours ago

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the…

8 hours ago